中文
| Catalogue |
|
|
| Recommend Products |
Company News
- Biocon Continues to be Among Science Magazine’s Top 10 Global Employers List 10/29/2024
- Biocon Biologics Partners with Sandoz for the Distribution of “Adalimumab BS Subcutaneou... 12/25/2023
- Biocon Biologics Continues to Expand Global Footprint, Completes Integration of Viatris Bi... 9/8/2023
- Biocon Biologics Announces Key Leadership Appointments 8/7/2023
- Biocon Biologics Announces Positive CHMP Opinion for YESAFILI®, Biosimilar Aflibercep... 7/25/2023
- Biocon Biologics Expands Footprint in Emerging Markets 7/6/2023
- Biocon Awarded a Silver Medal by EcoVadis for its Sustainability Accomplishments 4/3/2023
- Biocon Biologics Wins the ‘ABEA : Bioprocessing Excellence in South Asia’ Award 3/29/2023
- Biocon Biologics Recognized as a Company with Great Managers 12/23/2022
- Shreehas Tambe Appointed as Managing Director & CEO of Biocon Biologics Limited 12/6/2022
- Biocon Biologics Features in the Prestigious ASIA IP ELITE List for 2022 11/14/2022
- Biocon Ranks at No. 8 in ‘Global Top Employers’ List by the U.S. Science Magazine 11/1/2022
- Biocon Biologics Out-Licenses Two Biosimilar Assets to Yoshindo for Commercialization in J... 10/17/2022
- Biocon Sdn. Bhd. Enters Malaysia Book of Records as the First & the Largest Integrated Ins... 8/8/2022
- Biocon Biologics and Viatris Launch Abevmy® (bBevacizumab), Their Third Oncology Bios... 5/27/2022
- Biocon Biologics’ Partner Receives Positive EU CHMP Opinion for Biosimilar Human Insulin f... 4/2/2022
- Kiran Mazumdar-Shaw Elected as the Fellow of Royal Society of Edinburgh (RSE) 3/24/2022
- Biocon Biologics to Acquire Viatris’ Biosimilars Assets for up to USD 3.335 Billion in Sto... 2/28/2022
- Biocon Enters Prestigious Dow Jones Sustainability Emerging Markets Index 12/2/2021
- Biocon Biologics and Viatris Announce Launch of Interchangeable SEMGLEE® Injection an... 11/17/2021